To conclude, the current findings suggest that ME predictive scores are more relevant and informative compared to other online tools and with an additional AR IHC expression analysis the recurrence prediction might prove to be beneficial and feasible to many deprived BC patients. The gene discussed is AR; the disease is breast cancer.